|New from NCI|
|Video—Update on US Cancer Survival: Did You Know?|
| ||Watch this video to learn about factors that affect cancer survival rates, improvements in screening and treatment, and the 5-year survival rates for several types of cancer.|
|For Some Patients with Melanoma, Removing More Lymph Nodes Does Not Improve Survival|
| ||Results from a large international clinical trial suggest that a conservative approach to lymph node surgery may be best for people with melanoma that has spread from the skin to only one or a small number of nearby lymph nodes.|
|FDA Approves Pembrolizumab for Tumors with Specific Genetic Features|
| ||The Food and Drug Administration (FDA) approved the targeted therapy drug pembrolizumab for patients with solid tumors that have specific genetic features. This is the first approval based on genetic features, rather than where in the body the cancer began.|
|Targeted Therapy Approved for ALK-positive Non-Small Cell Lung Cancer|
FDA has approved the targeted therapy drug ceritinib for non-small cell lung cancer that has a change in the ALK gene.
|Test Could Reduce Unnecessary Biopsies to Detect Prostate Cancer|
Findings from a new study show testing for two markers in urine may help some men avoid an unnecessary biopsy to detect prostate cancer.
|PDQ Summary Updates|
|Oropharyngeal Cancer Treatment|
We updated many sections of our PDQ summary on oropharyngeal cancer treatment, especially the sections on treatment for stages III, IV, and recurrent oropharyngeal cancer.
No hay comentarios:
Publicar un comentario